IMMUNOLOGICAL PROGNOSTIC VARIABLES IN STAGE II MALIGNANT-MELANOMA - RELATIONSHIP TO SURVIVAL AND DISEASE-FREE INTERVAL (DFI)

被引：0
|
作者：
BUKOWSKI, RM [1 ]
HEWLETT, JS [1 ]
GREENSTREET, R [1 ]
DEODHAR, SH [1 ]
机构：
[1] CLEVELAND CLIN EDUC FDN,CLEVELAND,OH 44106
来源：
CLINICAL RESEARCH | 1979年 / 27卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A382 / A382
页数：1
相关论文
共 50 条
  • [1] MALIGNANT-MELANOMA - SIGNIFICANCE OF DISEASE-FREE INTERVAL
    YARNOLD, JR
    COCHRANE, JPS
    BRITISH JOURNAL OF RADIOLOGY, 1980, 53 (635): : 1068 - 1070
  • [2] RECURRENT MALIGNANT-MELANOMA FOLLOWING A 35-YEAR DISEASE-FREE INTERVAL
    TAHERY, DP
    MOY, RL
    JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1993, 19 (02): : 161 - 163
  • [3] RECURRENT MALIGNANT-MELANOMA FOLLOWING A 46-YEAR DISEASE-FREE INTERVAL
    ROSENKRANZ, L
    SCHROEDER, C
    NEW YORK STATE JOURNAL OF MEDICINE, 1985, 85 (03) : 95 - 95
  • [4] THE EFFECTS OF NEGATIVE REGIONAL LYMPH-NODE DISSECTION ON SURVIVAL AND DISEASE-FREE INTERVAL OF PATIENTS WITH STAGE-I MALIGNANT-MELANOMA
    VANEGMOND, DB
    WELVAART, K
    HERMANS, J
    RUITER, DJ
    NETHERLANDS JOURNAL OF SURGERY, 1990, 42 (02): : 43 - 46
  • [5] RELATIONSHIP BETWEEN DISEASE-FREE INTERVAL AND SURVIVAL IN PATIENTS WITH RECURRENT MELANOMA
    CROWLEY, NJ
    SEIGLER, HF
    ARCHIVES OF SURGERY, 1992, 127 (11) : 1303 - 1308
  • [6] THE EFFECTS OF NEGATIVE REGIONAL LYMPH-NODE DISSECTION ON SURVIVAL AND DISEASE-FREE INTERVAL OF PATIENTS WITH STAGE-I MALIGNANT-MELANOMA - REPLY
    WELVAART, K
    NETHERLANDS JOURNAL OF SURGERY, 1990, 42 (06): : 161 - 162
  • [7] A PROGNOSTIC FACTOR STUDY OF DISEASE-FREE INTERVAL AND SURVIVAL FOLLOWING ENUCLEATION FOR UVEAL MELANOMA
    SEDDON, JM
    ALBERT, DM
    LAVIN, PT
    ROBINSON, N
    ARCHIVES OF OPHTHALMOLOGY, 1983, 101 (12) : 1894 - 1899
  • [8] IMMUNOTHERAPY OF HUMAN SOLID TUMORS WITH BACILLUS-CALMETTE-GUERIN - PROLONGATION OF DISEASE-FREE INTERVAL AND SURVIVAL IN MALIGNANT-MELANOMA, BREAST, AND COLORECTAL CANCER
    GUTTERMAN, JU
    MAVLIGIT, GM
    BLUMENSHEIN, G
    BURGESS, MA
    MCBRIDE, CM
    HERSH, EM
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1976, 277 (SEP20) : 135 - 159
  • [9] Obesity is not associated with disease-free interval, melanoma-specific survival, or overall survival in patients with clinical stage IB-II melanoma after SLNB
    Deckers, Eric A.
    Kruijff, Schelto
    Bastiaannet, Esther
    van Ginkel, Robert J.
    Hoekstra-Weebers, Josette E. H. M.
    Hoekstra, Harald J.
    JOURNAL OF SURGICAL ONCOLOGY, 2021, 124 (04) : 655 - 664
  • [10] MicroRNA biomarkers prognostic for disease-free and overall survival in stage I and II lung adenocarcinoma
    Weiss, Glen J.
    Cherni, Irene
    Paquette, Kim A.
    Metpally, Raghu
    Whitsett, Tim G.
    Allen, Jeffrey
    Kim, Seungchan
    Hua, Jianping
    Tembe, Waibhav D.
    Lorenzo, Carlos D.
    Kurywchak, Paul A.
    Malik, Mohsin
    Raz, Guy M.
    Wagner, Walter P.
    Tran, Nhan L.
    CANCER RESEARCH, 2012, 72
12345